Neo, your view on orbis positioning re oncology has some merit IMO.
Could Orbis have achieved a split without driving the share price down? I can't see why not but I'm not much of a market watcher (more of a biotech 'value' investor).
the split I get (perhaps because I like it) but how this is connected to the share price drop when their position is still (proportionally) the same?
Happy for someone to educate me
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable